Ionis Pharmaceuticals | IONS - Assets


Ionis Pharmaceuticals reported $3.03B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Agios Pharmaceuticals USD 1.39B 85.53M Sep/2025
Alnylam Pharmaceuticals USD 4.85B 285.64M Sep/2025
Arrowhead Research USD 1.39B 4.68M Sep/2025
Astellas Pharma JPY 3.45T 114.46B Sep/2025
BioMarin Pharmaceutical USD 7.61B 158.53M Sep/2025
Celltrion KRW 21.08T 530.63B Sep/2025
Cspc Pharmaceutical CNY 46B 1.61B Jun/2025
Divis Laboratories Ltd INR 181.51B 12.19B Sep/2025
Exelixis USD 2.82B 145.47M Sep/2025
Halozyme Therapeutics USD 2.22B 167.33M Sep/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
Kangmei Pharma CNY 13.68B 38.19M Sep/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 66.4M 1.06M Jun/2025
Moderna USD 12.14B 125M Sep/2025
Neuren Pharmaceuticals AUD 331.25M 78.46M Jun/2025
Neurocrine Biosciences USD 4.27B 375.9M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
OPKO Health USD 2B 22.52M Sep/2025
Organigram Holdings CAD 562.21M 2.4M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Pharma Mar EUR 341.66M 6.59M Sep/2025
PTC Therapeutics USD 2.64B 9.54M Sep/2025
Qiagen NV USD 6.55B 729.74M Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sarepta Therapeutics USD 3.49B 186.38M Sep/2025
Sartorius EUR 9.61B 413.4M Sep/2025
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Tilray USD 2.07B 1.33B Mar/2025
Ultragenyx Pharmaceutical USD 1.19B 115.82M Sep/2025
Vertex Pharmaceuticals USD 24.86B 825.6M Sep/2025
Zz Pientze Pharmaceu CNY 17.48B 1.23B Sep/2025